Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Jul 13, 2020 05:14 PM IST | Source: Moneycontrol.com

Subscribe to Rossari Biotech: Arihant Capital

Arihant Capital has come out with its report on Rossari Biotech. The research firm has recommended to "Subscribe'' the IPO in its research report as on July 10, 2020

Broker Research

Arihant Capital's IPO report on Rossari Biotech

Rossari Biotech (RBL) is one of the leading specialty chemicals manufacturing Company in India catering to FMCG, apparel, poultry and animal feed industries. Product portfolio of the Company is categorized mainly into three categories i) Home, personal care and performance chemicals (HPPC) ii) Textile specialty chemicals (TSC) iii) Animal health and Nutrition products. Company operate its business in India as well as 17 foreign countries. As on 31st May, 2020, it had a range of 2,030 different products sold across the three product categories.

Valuation and Outlook

Due to rising demand for hand sanitizers, disinfectants, cleaning chemical manufactured by Rossari, its business performance has boomed. Thus, We recommend investors to ‘Subscribe’ for this issue.

For all IPO stories, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Jul 13, 2020 05:14 pm